[Efficacy and safety of BTK inhibitor, venetoclax and rituximab in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma].
Jiang R, Dai LMJ, Sha YQ, Xia Y, Miao Y, Qin SC, Wu W, Qiu JY, Bi HL, Wang L, Fan L, Xu W, Li JY, Zhu HY.
Jiang R, et al. Among authors: xu w.
Zhonghua Xue Ye Xue Za Zhi. 2023 Mar 14;44(3):247-250. doi: 10.3760/cma.j.issn.0253-2727.2023.03.012.
Zhonghua Xue Ye Xue Za Zhi. 2023.
PMID: 37356988
Free PMC article.
Chinese.
No abstract available.